Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	At risk
Total, all-cause mortality	Placebo	13
Total, all-cause mortality	Ivabradine	13
Total, all-cause mortality	Atrial Fibrillation (Low Rate)	7
Total, all-cause mortality	Atrial Fibrilaltion (Standard Rate)	7
Total, other adverse events	Placebo	13
Total, other adverse events	Ivabradine	13
Total, other adverse events	Atrial Fibrillation (Low Rate)	7
Total, other adverse events	Atrial Fibrilaltion (Standard Rate)	7
Total, serious adverse events	Placebo	13
Total, serious adverse events	Ivabradine	13
Total, serious adverse events	Atrial Fibrillation (Low Rate)	7
Total, serious adverse events	Atrial Fibrilaltion (Standard Rate)	7

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02247245/event-totals